LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 2 filers reported holding LOXO ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,011,000 | +368.1% | 7,220 | +471.2% | 0.01% | +350.0% |
| Q3 2018 | $216,000 | -71.3% | 1,264 | -70.8% | 0.00% | -71.4% |
| Q2 2018 | $752,000 | +315.5% | 4,332 | +175.6% | 0.01% | +600.0% |
| Q1 2018 | $181,000 | +53.4% | 1,572 | +12.2% | 0.00% | 0.0% |
| Q4 2017 | $118,000 | -81.1% | 1,401 | -79.3% | 0.00% | -80.0% |
| Q3 2017 | $624,000 | +173.7% | 6,771 | +137.8% | 0.01% | +150.0% |
| Q2 2017 | $228,000 | -17.4% | 2,847 | -66.9% | 0.00% | 0.0% |
| Q4 2016 | $276,000 | – | 8,595 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |